Benefits of deacetylase inhibitors for leukemia therapy
Exploiting signalling pathways involved in CLL to develop novel therapies
Moving away from the follicular lymphoma international prognostic index
The rise of MRD in multiple myeloma: could this be an answer to a cure?
How can we overcome ibrutinib resistance?